Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma.

已完结 100 由医休发布于 2026/8/4 9:11:48

DOI:10.1056/nejmoa2513918
作者：Guo-Ming Shi,Xiao-Yong Huang,Fei Liang,Xiao Liang,Rui Dong,Qing-Hai Ye,Qiang Gao,Yuan Ji,Zheng-Ping Yu,Wen-Long Zhai,Jia-Cheng Lu,Xiao-Wu Li,Fu-Bao Liu,Kui Wang,Wei Yang,Jia-Lin Zhang,Zhi-Qiang Hu,Shu
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1056/nejmoa2513918

New England Journal of Medicine (NEJM)

Abstract：BACKGROUND No neoadjuvant treatment has been considered to be standard therapy for patients with resectable intrahepatic cholangiocarcinoma with high-risk factors for recurrence. The GOLP r

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierMulti-stable mechanisms for high-efficiency and broadband ocean wave energy harvesting